The invention provides novel &bgr;
2
adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with &bgr;
2
adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
本发明提供了一种新型的β2
肾上腺素能受体激动剂化合物。本发明还提供了包含该化合物的药物组合物,以及使用该化合物治疗与β2
肾上腺素能受体活性相关疾病的方法,以及用于制备该化合物的过程和中间体。